Trupanion (NASDAQ:TRUP) Issues Quarterly Earnings Results

Trupanion (NASDAQ:TRUP) issued its earnings results on Thursday. The financial services provider reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.01), FiscalAI reports. Trupanion had a net margin of 1.10% and a return on equity of 4.48%. The business had revenue of $376.85 million during the quarter, compared to analyst estimates of $375.89 million.

Trupanion Trading Down 0.6%

TRUP traded down $0.19 during trading on Thursday, reaching $32.14. 900,728 shares of the company’s stock were exchanged, compared to its average volume of 438,015. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.31. Trupanion has a one year low of $30.54 and a one year high of $57.88. The firm has a fifty day moving average price of $35.14 and a two-hundred day moving average price of $40.30. The stock has a market capitalization of $1.39 billion, a PE ratio of 89.28 and a beta of 1.58.

Insider Transactions at Trupanion

In related news, CFO Fawwad Qureshi sold 6,202 shares of the business’s stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $35.45, for a total value of $219,860.90. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO John R. Gallagher sold 6,383 shares of the firm’s stock in a transaction on Friday, November 28th. The stock was sold at an average price of $34.82, for a total value of $222,256.06. Following the transaction, the chief operating officer directly owned 32,721 shares of the company’s stock, valued at approximately $1,139,345.22. This represents a 16.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 32,853 shares of company stock worth $1,181,863. Company insiders own 5.42% of the company’s stock.

Institutional Trading of Trupanion

Several institutional investors have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC acquired a new stake in Trupanion in the fourth quarter worth $224,000. Dimensional Fund Advisors LP boosted its position in shares of Trupanion by 12.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 607,022 shares of the financial services provider’s stock worth $22,686,000 after purchasing an additional 66,069 shares in the last quarter. Swiss National Bank grew its stake in shares of Trupanion by 2.3% in the 4th quarter. Swiss National Bank now owns 63,610 shares of the financial services provider’s stock valued at $2,377,000 after buying an additional 1,400 shares during the period. Nuveen LLC increased its position in Trupanion by 6.4% in the 4th quarter. Nuveen LLC now owns 101,625 shares of the financial services provider’s stock valued at $3,798,000 after buying an additional 6,089 shares in the last quarter. Finally, Los Angeles Capital Management LLC raised its stake in Trupanion by 73.0% during the 4th quarter. Los Angeles Capital Management LLC now owns 23,000 shares of the financial services provider’s stock worth $931,000 after buying an additional 9,703 shares during the period.

Analysts Set New Price Targets

A number of research analysts have issued reports on TRUP shares. Stifel Nicolaus decreased their target price on Trupanion from $42.00 to $38.00 and set a “hold” rating on the stock in a research report on Thursday, January 29th. Piper Sandler decreased their price target on shares of Trupanion from $67.00 to $60.00 and set an “overweight” rating on the stock in a report on Friday, December 19th. Cantor Fitzgerald lowered their price objective on shares of Trupanion from $50.00 to $42.00 and set a “neutral” rating for the company in a research report on Wednesday, January 14th. Wall Street Zen lowered shares of Trupanion from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Finally, Zacks Research raised shares of Trupanion from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 6th. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $50.00.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.